ÈËÉú¾ÍÊDz©

EN
ÈËÉú¾ÍÊDz©_Ê×Ò³Èë¿Ú ÈËÉú¾ÍÊDz©_Ê×Ò³Èë¿Ú
ÐÂÎÅÖÐÐÄ
2023-06-15
ÎÒ¹ú¿ÆÑ§¼ÒʹÓÃÉñ¾­¸Éϸ°ûÁªºÏÍâÃÚÌåÖÎÁÆÈ±ÑªÐÔÄÔ×äÖÐ
ÒÆÖ²Éñ¾­¸Éϸ°û£¨Neural stem cell£¬£¬NSC£©Òѱ»Ö¤ÊµÄÜÔö½ø°üÀ¨È±ÑªÐÔÄÔ×äÖеȴóÄÔ¼²²¡µÄ¹¦Ð§¿µ¸´¡£¡£È»¶ø£¬£¬ÓÉÓÚȱѪÐÔÄÔ×äÖб¬·¢ºó£¬£¬´óÄÔ΢ÇéÐα°ÁÓ£¬£¬NSCµÄ´æ»îÂʺͷֽâÂʽϵÍ£¬£¬½ø¶øÓ°ÏìÖÎÁÆÐ§¹û¡£¡£» £»£»ªÖÐũҵ´óѧÑо¿ÍŶÓÕ¹ÏÖNSCÁªºÏNSCȪԴµÄÍâÃÚÌå¶ÔȱѪÐÔÄÔ×äÖоßÓÐÏÔÖøµÄÖÎÁÆÐ§¹û¡£¡£¸ÃÑо¿Ð§¹ûÓÚ¿ËÈÕ½ÒÏþÔÚ¡¶eLife¡·ÔÓÖ¾ÉÏ£¬£¬ÌâΪ£ºNSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in mice¡£¡£
ÔĶÁ¸ü¶à
2023-06-14
ÃÀ¹úÑÐÖÆ³öÓÃÓÚ»ùÒòÁÆ·¨µÄ³¬´óÈÝÁ¿²¡¶¾ÔØÌå
ÃÀ¹úÌìÖ÷½Ì´óѧµÄÑо¿ÍŶÓÔÚÐÂÒ»ÆÚ¡¶×ÔÈ»-ͨѶ¡·ÔÓÖ¾ÉϽÒÏþÂÛÎijÆ£¬£¬ÈËÔ첡¶¾ÔØÌå²»µ«¿ÉÒÔÔËËͺܳ¤µÄÍÑÑõºËÌǺËËᣨDNA£©Á´£¬£¬»¹ÄÜͬʱ´îÔØ¶àÖÖÆäËû·Ö×Ó£¬£¬Ò»´ÎÐÔ¶Ôϸ°û¾ÙÐжàÏîÐÞ¸´ºÍˢС£¡£
ÔĶÁ¸ü¶à
2023-06-09
Ô´×ÔÆ¤·ôϸ°ûµÄÄÉÃ׿ÅÁ£¿£¿ £¿£¿£¿ÉÖηβ¡
ÃÀ¹ú¶íº¥¶íÖÝÁ¢´óѧµÄÒ»ÏîÐÂÑо¿ÏÔʾ£¬£¬ÓɳÉÈËÆ¤·ôϸ°ûÉè¼ÆµÄÖÎÁÆÐÔÄ˽×ÔØÌå¿ÉÒÖÖÆÐ¡ÊóÊÜËð·Î²¿µÄÑ×Ö¢ºÍ×éÖ¯ËðÉË£¬£¬ÕâÒâζ×ÅÈËÃÇÓÐÍûÖÎÁÆÒòѬȾ»ò´´É˶øÑÏÖØÊÜËðµÄ·Î¡£¡£ÕâÊÇÒ»ÖÖ¾Ö²¿ÖÎÁÆ£¬£¬¿É¾­±ÇÇ»¸øÒ©²¢ÁôÔÚ·ÎÀï¡£¡£Ïà¹ØÑо¿ÔÚÏß½ÒÏþÓÚ×î½üµÄ¡¶ÏȽøÖÊÁÏ¡·ÔÓÖ¾¡£¡£
ÔĶÁ¸ü¶à
2023-06-08
Èí»¯Ã«ÄÒ¸Éϸ°ûÄÜ´Ù뱬·¢³¤
ÕýÈçÈËÃǵÄÊàŦ»áËæ×ÅÄêËêÔöÌí¶ø±äµÃ½©Ó²£¬£¬Ê¹ÈËÔ˶¯ÄÑÌâÒ»Ñù£¬£¬Ã«ÄÒ¸Éϸ°ûÒ²»á±äµÃ½©Ó²£¬£¬ÈÃÈ˸üÄѳ¤³öÃæ·¢¡£¡£ÏÖÔÚ£¬£¬ÃÀ¹úÎ÷±±´óѧµÈ»ú¹¹¿ÆÑ§¼ÒÔÚ×îÐÂÒ»ÆÚ¡¶ÃÀ¹ú¹ú¼Ò¿ÆÑ§ÔºÔº¿¯¡·ÉϽÒÏþÂÛÎijÆ£¬£¬ËûÃÇÔÚʵÑéÊóÄ£×ÓÉÏ¿ªÕ¹µÄÒ»Ïî×îÐÂÑо¿·¢Ã÷£¬£¬Èí»¯½©Ó²µÄëÄÒ¸Éϸ°û¿ÉÔö½ø¶¯Îﳤ³öë·¢¡£¡£
ÔĶÁ¸ü¶à
2023-06-07
»îϸ°û3D´òÓ¡³ÉÈËÌå×éÖ¯
¶íÂÞ˹лÇÐŵ·òĪ˹¿ÆµÚÒ»¹úÁ¢Ò½¿Æ´óѧºÍ¶íÂÞ˹¿ÆÑ§ÔºÐ»Ãçŵ·ò»¯Ñ§ÎïÀíÖÐÐÄÏàÖú£¬£¬Ñз¢³öʹÓûîϸ°û¶ÔÈËÌå×éÖ¯¾ÙÐÐÈýάÉúÎï´òÓ¡µÄÊÖÒÕ£¬£¬Ê¹ÎªÌض¨ÈËȺ´òÓ¡Æ÷¹ÙºÍ×éÖ¯³ÉΪ¿ÉÄÜ¡£¡£ ¶í¿ÆÑ§¼ÒÒѾ­Íê³ÉÁËÒ»¸ö3DÉúÎï´òÓ¡ÖÜÆÚ£¬£¬²¢»ñµÃÁËÉúÎï×éÖ¯µÈЧÎ£¬ÕâÊÇÒ»ÖÖÈ˹¤´òÓ¡µÄÈËÌå×éÖ¯»îÌå¡£¡£
ÔĶÁ¸ü¶à
2023-06-06
¿ÆÑ§¼ÒÕ¹ÏÖhPSCÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾­²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢
Ê©Íòϸ°û£¨Schwann cells£¬£¬SC£©ÊÇÖÜΧÉñ¾­ÏµÍ³ÖÐÖ÷ÒªµÄ½ºÖÊϸ°û¡£¡£SCÓëÐí¶à¼²²¡ÓйØ£¬£¬ÌÇÄò²¡ÖÜΧÉñ¾­²¡±ä£¨Diabetic peripheral neuropathy£¬£¬DPN£©ÊÇÆäÖÐÖ®Ò»¡£¡£ÃÀ¹ú¼ÓÖÝ´óѧ¾É½ðɽ·ÖУÑо¿Ö°Ô±·¢Ã÷£¬£¬È˶àÐÑĿϸ°û£¨human pluripotent stem cell£¬£¬hPSC£©ÑÜÉúµÄÊ©Íòϸ°û¿ÉÓÃÓÚÌÇÄò²¡ÖÜΧÉñ¾­²¡±äµÄ¼²²¡½¨Ä£ºÍÒ©ÎïÑз¢¡£¡£¸ÃÑо¿Ð§¹ûÓÚ¿ËÈÕ½ÒÏþÔÚ¡¶Cell Stem Cell¡·ÔÓÖ¾ÉÏ£¬£¬ÌâΪ£ºDeriving Schwann cells from hPSCs enables disease modeling and drug discovery for diabetic peripheral neuropathy¡£¡£
ÔĶÁ¸ü¶à
2023-05-29
´ÅÉùÇý¶¯µÄCAR-Tϸ°û΢ÐÍ»úеÈË¿¹°©¸ü¾«×¼
¸ÃÑо¿¿ª·¢ÁËÒ»ÖÖ»ùÓÚCAR-Tϸ°ûµÄ΢ÐÍ»úеÈË£¨M-CAR T£©£¬£¬ÓÐÍûÈÿ¹°©¸ü¾«×¼¡£¡£
ÔĶÁ¸ü¶à
2023-05-23
ÎÒ¹ú¿ÆÑ§¼ÒÑз¢ÄÉÃ×ÄÒÅÝת´ï¿¹ÌåÔöÇ¿µÄ¿¹Ö×ÁöÃâÒßÁ¦
CD47/PD-L1¿¹Ìå×éºÏÌåÏÖ³ö³¤ÆÚµÄ¿¹Ö×ÁöÃâÒßÁ¦£¬£¬µ«ÆäÒ²»áÒýÆðÃâÒßÏà¹Ø²»Á¼ÊÂÎñ£¨IRAEs£©¶øÓ°ÏìÁÙ´²ÁÆÐ§¡£¡£ÄÏ·½Ò½¿Æ´óѧµÚÒ»Á¥ÊôÒ½ÔºÑо¿ÍŶÓÑз¢¾ÛºÏÎïÄÉÃ×ÄÒÅÝ£¬£¬ÓÃÓÚµÝËÍCD47/PD-L1¿¹Ì壬£¬ÔöÇ¿ÁË·ÎÏÙ°©µÄ¿¹Ö×ÁöÃâÒßÁ¦²¢½µµÍÁËÃâÒß¶¾ÐÔ¡£¡£¸ÃÑо¿Ð§¹ûÓÚ¿ËÈÕ½ÒÏþÔÚ¡¶Advanced Science¡·ÔÓÖ¾ÉÏ£¬£¬ÌâΪ£ºMicrofluidics-enabled nano-vesicle delivers CD47/PD-L1 antibodies to enhance anti-tumor immunity and reduce immunotoxicity in lung adenocarcinoma¡£¡£
ÔĶÁ¸ü¶à
¡¾ÍøÕ¾µØÍ¼¡¿